AMICUS THERAPEUTICS INC — Form D

AMICUS THERAPEUTICS INC of CRANBURY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-19. The offering totals $4.7M, of which $4.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (76)

Showing 25 of 76 people.

NameRoleLocation
Sol D BarerDirectorCranbury, NJ
John CrowleyDirectorAlameda, CA
Donald J Hayden, Jr.DirectorPhiladelphia, PA
Ted W LoveDirectorCranbury, NJ
Glen G SblendorioDirectorCranbury, NJ
William D Baird, IIIExecutive OfficerCranbury, NJ
John CrowleyExecutive OfficerAlameda, CA
Daphne D QuimiExecutive OfficerCranbury, NJ
David ClarkExecutive OfficerLafayette, CO
Bradley CampbellDirectorTampa, FL
Bradley CampbellExecutive OfficerTampa, FL
John F CrowleyDirectorPrinceton, NJ
John F CrowleyExecutive OfficerPrinceton, NJ
Eiry W Roberts, M.D.DirectorPrinceton, NJ
Ellen S RosenbergExecutive OfficerPrinceton, NJ
Craig A WheelerDirectorPrinceton, NJ
Michael A KellyDirectorPrinceton, NJ
Michael G RaabDirectorPrinceton, NJ
Simon HarfordExecutive OfficerPrinceton, NJ
Glenn P SblendorioDirectorPrinceton, NJ
Burke W WhitmanDirectorPrinceton, NJ
Lynn D BleilDirectorPrinceton, NJ
Jeffrey P Castelli, Ph.D.Executive OfficerPrinceton, NJ
Samantha M ProutExecutive OfficerPhiladelphia, PA
Eiry L RobertsDirectorPhiladelphia, PA

Other filings by this issuer (6)

FiledFormOfferingSold
2023-10-16D$30.0M$30.0M
2021-10-13D$199.9M$199.9M
2013-12-03D$15.0M$15.0M
2013-12-03D$15.0M$15.0M
2012-07-30D$18.6M$18.6M
2010-11-05D$31.3M$31.3M

More